In Global News: Cyclist Will Bike 50-Mile Race Two Months After Quintuple Bypass Surgery, AI Tool to Diagnose Non-Small Cell Lung Cancer, and On-Pump Versus Off-Pump CABG

Patient Care and General Interest
A man who received quintuple bypass surgery in Little Rock, Arkansas, USA, plans to cycle a 50-mile race only two months later.
A woman in Denver, Colorado, USA, was told she had 6-9 months to live after being diagnosed with Stage 3 lung cancer; however, after participating in clinical trials for lung cancer treatment, she is doing well 10 years later.
 
Drugs and Devices
A hospital in New Jersey, USA, is testing an artificial intelligence device designed to detect bleeding during endovascular procedures.
The US Food and Drug Administration has approved the PK Papyrus covered coronary stent system for the treatment of acute coronary artery perforations during PCI, the first device to be approved for this indication in 17 years.
A study by the New York University School of Medicine in New York City suggests that an artificial intelligence tool can diagnose non-small cell lung cancer types with 97 percent accuracy.
 
Research, Trials, and Funding
A paper published in the Irish Journal of Medical Science indicates that undetected cases of high cholesterol are adding to the incidence of cardiovascular disease, which is the greatest cause of death in Ireland.
A Journal of the American College of Cardiology study of off-pump versus on-pump CABG suggests that the on-pump approach provides superior long-term survival.